Insulin Delivery Devices Market Development and Forecast to 2020

Insulin Delivery Devices Market Development and Forecast to 2020

ID: MRFR/HC/0352-CRR | August, 2016 | Region: Global | 77 pages | Cooked Research Reports

Insulin Delivery Devices Market, by type (Insulin Syringe, Insulin Pumps, Insulin Pens, Insulin Jet Injectors) - Forecast to 2020


 
Study objectives of Insulin Delivery Devices Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the insulin delivery devices market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on porters five force analysis

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Rest of World.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, products and services, new product developments, and research and developments in the global insulin delivery device  



GLOBAL INSULIN DELIVERY DEVICE MARKET SHARE BY TYPE, 2013
                        

                      


                      


 Intended Audience



  • Insulin Delivery Device manufacturers and suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Academic Institutes and Universities



Market Synopsis of Insulin Delivery Devices Market:

Market Scenario:


Diabetes is a chronic disease caused due to inadequate production or inappropriate use of insulin in the body. It mainly comprises two types which is Type 1 and Type 2 diabetes. Insulin is delivered with the help of various delivery devices such as insulin pumps, pen injectors, insulin syringe and jet injectors. Increasing prevalence of diabetes, rising obesity endemic, increasing awareness among people about diabetic care and technological advancement in delivery devices are some of the factors affecting the growth of the insulin delivery device market. Globally the market for Insulin Delivery Device is anticipated to grow at the rate of about 6.9% from 2014 to 2020.



Key Finding



  • The insulin delivery devices global market and is expected to reach $14.21 billion by 2020.

  • Insulin syringe hold the largest share of the market.

  • Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 7.9% during the forecast period.



Segments:                                                                                                                                          

Insulin Delivery Devices market has been segmented on the basis of type which comprises of Insulin Syringe, Insulin Pumps, Insulin Pens, Insulin Jet Injectors.


  
Regional Analysis of Insulin Delivery Devices Market:                                           


Globally North America is the largest market for insulin delivery devices. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for Insulin Delivery Devices.


 
Key Players for Insulin Delivery Devices Market:                                        


Some of the key players in this market are: F. Hoffmann-La Roche, Eli Lilly and Company, Sanofi, Medtronic, Inc, Novo Nordisk A/S and Becton, Dickinson and Company, B. Braun Melsungen AG, Animas Corporation, Ypsomed Holdings AG, and Insulet Corporation.


 
The report for
Insulin Delivery Devices market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

1.1 Market Definition 11

1.2 Market Breakdown by Type 11

1.3 Market Breakdown by Geography 11

1.4 Research Methodology and Sources 12

2.1 Key Findings 14

2.2 Research Summary 14

3.1 Introduction 16

3.2 Trends in the Market 18

3.2.1 Home infusion therapy is achieving significance in the treatment

of diabetes 18

3.2.2 Artificial pancreas is gaining popularity in the insulin delivery

device market 18

3.3 Factors Driving the Market and its Impact on Market Forecast 19

3.3.1 Increasing prevalence of diabetes 19

3.3.2 Rise in geriatric population 20

3.3.3 Rise in global obesity population 20

3.3.4 Technological advancement in drug delivery devices 22

3.3.5 Increasing awareness about diabetic care 22

3.3.6 Impact analysis of drivers on market forecast 22

3.4 Factors Hindering the Market and its Impact on Market Forecast 23

3.4.1 Hazards and risks associated with drug delivery devices 23

3.4.2 High insulin analogue cost 24

3.4.3 Impact analysis of restraints on market forecast 24

4.1 Global Market Breakdown by Type 25

4.2 Global Market Breakdown by Region 26

5.1 Insulin Syringe Market Breakdown by Region 28

5.2 Insulin Pump Market Breakdown by Region 29

5.3 Insulin Pen Market Breakdown by Region 31

5.4 Insulin Jet Injector Market Breakdown by Region 32

6.1 North America Market Breakdown by Country and Type 34

6.1.1 The U.S. market breakdown by type 36

6.1.2 Canada market breakdown by type 37

6.2 Europe Market Breakdown by Country and Type 39

6.2.1 Germany market breakdown by type 41

6.2.2 France market breakdown by type 43

6.2.3 The U.K. market breakdown by type 44

6.2.4 Italy market breakdown by type 45

6.2.5 Spain market breakdown by type 47

6.3 Asia Market Breakdown by Country and Type 48

6.3.1 Japan market breakdown by type 50

6.3.2 China market breakdown by type 52

6.3.3 India market breakdown by type 53

6.4 Rest of the World (RoW) Market Breakdown by Type 55

7.1 Porter's Five Forces of Competitive Position Analysis 57

7.1.1 Bargaining power of buyers 57

7.1.2 Bargaining power of suppliers 58

7.1.3 Threat of new entrants 58

7.1.4 Intensity of rivalry 58

7.1.5 Threat of substitutes 58

7.2 Competitive Positioning of Key Competitors and Market Share Analysis 59

8.1 Medtronic, Inc. 61

8.1.1 Business overview 61

8.1.2 Products and services offerings 61

8.1.3 Recent developments 62

8.1.4 Key P&L metrics 62

8.2 F. Hoffmann-La Roche, Ltd. 63

8.2.1 Business overview 63

8.2.2 Products and services offerings 63

8.2.3 Recent developments 64

8.2.4 Key P&L metrics 64

8.3 Abbott Laboratories, Inc. 64

8.3.1 Business overview 65

8.3.2 Products and services offerings 65

8.3.3 Recent developments 65

8.3.4 Key P&L metrics 66

8.4 Novo Nordisk A/S 66

8.4.1 Business overview 66

8.4.2 Products and services offerings 66

8.4.3 Recent developments 67

8.4.4 Key P&L metrics 67

8.5 Eli Lilly and Company 67

8.5.1 Business overview 68

8.5.2 Products and services offerings 68

8.5.3 Recent developments 68

8.5.4 Key P&L metrics 68

8.6 Sanofi 69

8.6.1 Business overview 69

8.6.2 Products and services offerings 69

8.6.3 Recent developments 70

8.6.4 Key P&L metrics 70

8.7 Becton, Dickinson and Company 70

8.7.1 Business overview 70

8.7.2 Products and services offerings 71

8.7.3 Recent developments 71

8.7.4 Key P&L metrics 71

8.8 B. Braun Melsungen AG 72

8.8.1 Business overview 72

8.8.2 Products and services offerings 72

8.8.3 Recent developments 73

8.8.4 Key P&L metrics 73

8.9 Animas Corporation 73

8.9.1 Business overview 73

8.9.2 Product and services offerings 74

8.9.3 Recent developments 74

8.9.4 Key P&L metrics 74

8.1 Ypsomed Holdings AG 75

8.10.1 Business overview 75

8.10.2 Products and services offerings 75

8.10.3 Recent developments 75

8.10.4 Key P&L metrics 76

8.11 Insulet Corporation 76

8.11.1 Business overview 77

8.11.2 Product and services offerings 77

8.11.3 Recent developments 77

8.11.4 Key P&L metrics 78